Nuvalent (NUVL) PT Raised at Piper Sandler; 'Upcoming ALKOVE-1 Update Underappreciated'
Tweet Send to a Friend
Piper Sandler analyst Kelsey Goodwin raised the price target on Nuvalent (NASDAQ: NUVL) to $128.00 (from $112.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
